دورية أكاديمية
Timing and predictors of death during treatment in patients with multidrug/rifampin-resistant tuberculosis in South Korea
| العنوان: | Timing and predictors of death during treatment in patients with multidrug/rifampin-resistant tuberculosis in South Korea |
|---|---|
| المؤلفون: | Eunjeong Son, Hongjo Choi, Jeongha Mok, Young Ae Kang, Dawoon Jeong, Doosoo Jeon |
| المصدر: | The Korean Journal of Internal Medicine, Vol 39, Iss 4, Pp 640-649 (2024) |
| بيانات النشر: | The Korean Association of Internal Medicine, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Medicine |
| مصطلحات موضوعية: | tuberculosis, multidrug resistance, death, risk factors, south korea, Medicine |
| الوصف: | Background/Aims This study aimed to investigate the timing and predictors of death during treatment among patients with multidrug/rifampin-resistant tuberculosis (MDR/RR-TB) in South Korea. Methods This was a retrospective cohort study that included MDR/RR-TB cases notified between 2011 and 2017 in South Korea. Results Among 7,226 MDR/RR-TB cases, 699 (9.7%) died at a median of 167 days (IQR 51–358 d) from the initiation of MDR-TB treatment. The cumulative proportion of all-cause death was 35.5% at 90 days and 52.8% at 180 days from treatment initiation. TB-related deaths occurred at a median of 133 days (IQR 32–366 d), which was significantly earlier than the median of 184 days (IQR 68–356 d) for non-TB-related deaths (p = 0.002). In a multivariate analysis, older age was the factor most strongly associated with death, with those aged ≥ 75 years being 68 times more likely to die (aHR 68.11, 95% CI 21.75–213.26), compared those aged ≤ 24 years. In addition, male sex, comorbidities (cancer, human immunodeficiency virus, and end stage renal disease), the lowest household income class, and TB-specific factors (previous history of TB treatment, smear positivity, and fluoroquinolone resistance) were identified as independent predictors of all-cause death. Conclusions This nationwide study highlights increased deaths during the intensive phase and identifies high-risk groups including older people and those with comorbidities or socioeconomic vulnerabilities. An integrated and comprehensive strategy is required to reduce mortality in patients with MDR/RR-TB, particularly focusing on the early stages of treatment and target populations. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 1226-3303 2005-6648 |
| Relation: | http://www.kjim.org/upload/kjim-2024-029.pdf; https://doaj.org/toc/1226-3303; https://doaj.org/toc/2005-6648 |
| DOI: | 10.3904/kjim.2024.029 |
| URL الوصول: | https://doaj.org/article/8773028180104247a566a74b041e6190 |
| رقم الأكسشن: | edsdoj.8773028180104247a566a74b041e6190 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 12263303 20056648 |
|---|---|
| DOI: | 10.3904/kjim.2024.029 |